CGIX News Alert Cancer Genetics Inc (CGIX) 6.30 12/13/2014 0

New Post Public Reply Private Reply Replies (0) Message Board

Dec 13, 2014 at 2:09 AM

Cancer Genetics Inc (CGIX) 6.30 $CGIX

Insider Trading Alert - CGIX, NBY And BIOA Traded By Insiders
at The Street - Fri Dec 12, 10:15AM CST
Stocks with insider trader activity include CGIX, NBY and BIOA
BIOA: 8.60 (+0.14), NBY: 0.69 (+0.09), CGIX: 6.30 (unch)

Insider Trading Alert - CDW, CGIX And RDNT Traded By Insiders
at The Street - Thu Dec 11, 12:15PM CST
Stocks with insider trader activity include CDW, CGIX and RDNT
RDNT: 8.56 (+0.03), CGIX: 6.30 (unch), CDW: 34.33 (+0.22)

Cancer Genetics (CGIX) Looks Good: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 8:25AM CST
Cancer Genetics (CGIX) was a big mover last session, with shares rising just over 8% on the day.
Q: 57.37 (-0.11), CRL: 62.66 (-0.32), ICLR: 50.86 (-0.10), CGIX: 6.30 (unch)

Cancer Genetics, Inc. Strengthens Clinical Trials Leadership Team With Hire of Rob Fannon as Vice President of Operations
GlobeNewswire - Wed Dec 10, 6:30AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"

, an emerging leader in DNA-based cancer diagnostics, announced today that Rob Fannon has joined the company as vice president of operations in the Raleigh/Research Triangle Park (RTP), North Carolina location. Fannon, previously with Roche Molecular's BioSpecimen Management division, brings more than 10 years of operations, client management, molecular test and panel development, and biorepository management experience to CGI.
CGIX: 6.30 (unch)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:45AM CST

BLUE: 91.28 (+5.16), SC: 17.65 (-0.71), ANV: 0.74 (-0.04), UTIW: 11.07 (-0.33), AKAO: 11.91 (-0.31), CLDN: 17.25 (+0.75), MZOR: 14.30 (+0.10), NBG: 1.79 (-0.01), TTI: 5.06 (-0.34), TPLM: 4.06 (-0.18), CGIX: 6.30 (unch), LCI: 43.58 (-0.46), SAVE: 68.12 (-0.88), PQ: 3.46 (-0.11), AFMD: 5.38 (-0.34), ENSV: 1.48 (-0.02), CTC: 0.77 (+0.01), CONN: 17.44 (+0.35), PDCE: 33.13 (-0.89), KPTI: 34.85 (+1.35)

Cancer Genetics, Inc. to Receive $530,000 Through New Jersey Technology Business Tax Program
GlobeNewswire - Tue Dec 09, 8:12AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"

, an emerging leader in DNA-based cancer diagnostics, announced today that it has received preliminary approval for a $570,000 tax credit from the New Jersey Technology Business Tax Certificate Transfer Program for the year 2014. The company anticipates that it will be able to transfer this credit and receive approximately $530,000 in cash in mid-December.
CGIX: 6.30 (unch)

Cancer Genetics, Inc. Announces Launch of Targeted Next Generation Sequencing Based Panel for Chronic Lymphocytic Leukemia, Focus::CLL
GlobeNewswire - Mon Dec 08, 6:30AM CST
-- Only NGS-based panel for CLL that offers information for patient risk stratification, disease management, and treatment selection
CGIX: 6.30 (unch)

RedChip Receives Top Praise for Its Performance
GlobeNewswire - Thu Dec 04, 8:45AM CST
RedChip Companies, Inc. ("RedChip"

, an international small-cap research, investor relations, and media company, receives top praise for its performance from its long list of distinguished microcap and small-cap clients.
CGIX: 6.30 (unch)

Cancer Genetics Inc. Announces the Appointments of Dr. Howard McLeod and Geoffrey Harris to Its Board of Directors
GlobeNewswire - Wed Dec 03, 4:41PM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"

, an emerging leader in DNA-based cancer diagnostics, announced today the addition of Howard McLeod, Pharm. D., and Geoffrey Harris to the Company's Board of Directors.
CGIX: 6.30 (unch)

Cancer Genetics, Inc. to Present at 26th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Mon Dec 01, 6:55AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"

, an emerging leader in DNA-based cancer diagnostics, announced today that it will present at the 26 Annual Piper Jaffray Healthcare Conference in New York on Tuesday, December 2, 2014. Representatives from the company will speak at 8:10 am EST.
CGIX: 6.30 (unch)

Cancer Genetics, Inc. to Present at American Society of Hematology (ASH) Annual Meeting
GlobeNewswire - Mon Nov 17, 6:50AM CST
-- Cancer Genetics will present two posters on diffuse large B-cell lymphoma (DLBCL), the most common form of B-cell cancers.
CGIX: 6.30 (unch)

Cancer Genetics, Inc. Recognized in Deloitte's 2014 Technology Fast 500(TM) Awards
GlobeNewswire - Fri Nov 14, 7:06AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the company"

, an emerging leader in DNA-based cancer diagnostics, today announced it ranked 303 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. CGI grew 296% percent as measured by revenues during this period.
CGIX: 6.30 (unch)

Cancer Genetics Inc to Present at Canaccord Genuity Medical Technology & Diagnostics Conference
GlobeNewswire - Thu Nov 13, 6:55AM CST
Cancer Genetics, Inc., (Nasdaq:CGIX) an emerging leader in DNA-based cancer diagnostics, announced today that the company's CEO, Panna Sharma, will present at the upcoming Canaccord Genuity Medical Technology & Diagnostics Conference. The event, which will be held at the Westin Grand Central in New York on Thursday, November 20, will profile over 80 public and private med-tech and diagnostic companies.
CGIX: 6.30 (unch)

Cancer Genetics wins second patent for FHACT test to improve cervical cancer detection for up to 2m women in the US each year
M2 - Wed Nov 12, 7:02AM CST
Cancer diagnostics company Cancer Genetics (NasdaqCM:CGIX) disclosed on Tuesday the receipt of the second US patent (US Patent No. 8,883,414) for its proprietary FISH-based HPV-Associated Cancer Test (FHACT) for cervical cancer detection in patients.
CGIX: 6.30 (unch)

RedChip Issues Research Note on Cancer Genetics
GlobeNewswire - Wed Nov 12, 7:00AM CST
RedChip Companies, Inc., today announced it has issued a research note on Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics that personalizes the clinical management of difficult-to-diagnose cancers.
CGIX: 6.30 (unch)

Cancer Genetics Inc to Present on Company's Targeted Next-Generation Sequencing Panels at AMP
GlobeNewswire - Wed Nov 12, 6:55AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"

, an emerging leader in DNA-based cancer diagnostics, announced today that it will present on its next generation sequencing (NGS) panels for hematological malignancies at the Association for Molecular Pathology's (AMP) 2014 Annual Meeting in Harbor, MD. Principal clinical scientist Charles Ma, Ph.D., will present "Developing NGS-based Clinical Assays for Hematological Neoplasms at CGI" on Wednesday, November 12 at 3 p.m. EST. The talk, which is sponsored by Illumina, will cover the development and clinical utility of the company'sNGS panels for hematologic malignancies, specifically for CLL (chronic lymphocytic leukemia) and Myeloid disorders.
CGIX: 6.30 (unch)

Cancer Genetics Inc Receives Second Patent for Genomic Cervical Cancer Test; Strengthens Position of FHACT(R)
GlobeNewswire - Tue Nov 11, 6:55AM CST
-- Company receives second patent (US Patent No. 8,883,414) for FHACT(R)
CGIX: 6.30 (unch)

Cancer Genetics' (CGIX) CEO Panna Sharma on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 11:28AM CST

CGIX: 6.30 (unch)

Cancer Genetics ups revenues 88% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 11:03AM CST

CGIX: 6.30 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Magnolia's Data Breach Raises Eyebrows and Concerns

Data Security Breach: Today's Digital Nightmare In the relentless digital jungle we live in, someone’s email account is like a treasure trove for cybercriminals sniffing around for their next haul. And that’s precisely what went down at Magnolia Management Company, LLC out in East Longmeadow, Massachusetts. It was April 3, 2026, when they stumbled upon some...

Spire Missouri's Rate Hike: Safety or Financial Squeeze?

A Rate Hike Tied to Safety or a Customer Burden? Listen up, what we've got here is Spire Missouri stamping down with a rate hike to bolster safety and reliability. It's a classic gas provider move, asking the Missouri Public Service Commission to greenlight this hike that’d have bills going up—$10 in the west, $13 in the east. That's 11% and 15% jumps. Not small...

Steven Johnson Boosts Latham's Tax Team in D.C.

Another Day, Another Big Hire in D.C. You'd think the revolving doors at these law firms were tied to Wall Street's cycles. Latham & Watkins, one heavyweight in the legal arena, is pulling a classic power move, snapping up Steven Johnson for their Washington, D.C. office. He ain't just some guy off the street; Johnson's got a résumé that reads like a textbook on federal...

Lincoln Avenue's Bold New Move: Affordable Senior Living

A New Senior Housing Era Begins in Channahon If there's one thing the affordable housing game loves, it's the mix of ambition and grit—both of which Lincoln Avenue Communities (LAC) brings to the table with The Talia. This latest project in Channahon, Illinois, marks their fourth groundbreaking in the state, cementing LAC's place as a key player in providing quality...

Bird-X Welcomes Doolittle to Elevate Sales Strategy

Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...

Chemours Faces Legal Woes: Investor Actions by Dec. 7

A Rough Road Ahead for Chemours Investors Well, folks, Chemours Company isn’t exactly living its best life right now. Following a tumble of 18.63% in its stock price after less-than-stellar second-quarter earnings, the legal hounds are circling the wagons. Investors who picked up shares between February 20, 2026, and August 4, 2026, might be feeling a bit sore right...

Gamehaus Expands with Anamana AI-Driven Acquisition

Gamehaus Moves Deep Into AI Waters Sailing right into a new frontier, Gamehaus is all set to splash $19.6 million for a hefty slice of Techforge, the parent of the AI-powered Anamana. Gamehaus: a game publisher taking aim at becoming an AI content giant. You might ask yourself, "Can they pull it off?" Well, that's what I'm pondering over my lukewarm coffee today....

Academy Sports Teams Up With Little Debbie for Holidays

Collaboration Brews Between Academy and Little Debbie Holiday cheer isn't complete without a mash-up that gets tongues wagging and wallets opening. Only this time, a sporting goods giant and your favorite snack cake brand are bringing us the yuletide spirit. Academy Sports + Outdoors has teamed up with Little Debbie for a limited-time collaboration under its Magellan...

MemorialCare Expands Cutting-Edge GERD Treatment Options

Shifting the GERD Treatment Paradigm While everyone's talking about breakthrough technologies like AI and blockchain in medicine, MemorialCare seems to have quietly flipped the script on treating gastroesophageal reflux disease (GERD). They're sidestepping conventional maneuvers by embracing two procedures known as transoral incisionless fundoplication (TIF) and its...

Lectric Rolls Out Limited-Edition XP4 Ebike Upgrades

Pedaling into a New Era of eBikes When the top contender in the American eBike world rolls out something new, you'd better believe it's worth a look. Lectric eBikes has just unwrapped three limited-edition versions of their beloved XP4, revealing a fresh take on a ride already admired by thousands. Let's dig into this new release. What's New with the XP4 This ain't just a...